首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >High-Throughput Proteomics Platform Demonstrated for Liver Disease Progression Biomarker Verification
【24h】

High-Throughput Proteomics Platform Demonstrated for Liver Disease Progression Biomarker Verification

机译:高通量蛋白质组学平台展示肝病进展生物标志物验证

获取原文

摘要

Application of an LC-IMS-QTOF MS platform allowed high throughput analysis in a large verification phase that will eventually include over 500 patients. A preliminary set of 29 statistically significant peptides/proteins that discriminate fibrosis progression were identified from pooled samples in the discovery phase. Analysis of 120 individual patient serum samples by LC-IMS-QTOF MS for the verification phase confirmed significant variation in 4 of the 29 statistically significant proteins. Current results are also being correlated with complementary proteomic liver biopsy data and literature for mechanistic understanding of protein serum expression profiles.
机译:LC-IMS-QTOF MS平台的应用允许高通量分析在大型验证阶段,最终包含超过500名患者。在发现阶段的合并样品中鉴定了鉴别纤维化进展的初步组形统计学显着的肽/蛋白质。通过LC-IMS-QTOF MS分析120个单独的患者血清样品,用于验证阶段证实了29个统计学显着的蛋白质中4的显着变化。目前的结果也与蛋白质血清表达谱的机械理解的互补蛋白质组学肝脏活组织检查数据和文献相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号